CompaniesAugmenix

Augmenix

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

228

By Phase

NA: 1PHASE3: 1

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT01538628
NCT03307564
Hover over trial bars to see details

Recent Trials

NCT03307564Collaborator
Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer
NACompleted
6 participants
Started: Jun 6, 2018 · Completed: Dec 31, 2022
NCT01538628Collaborator
SpaceOAR System Pivotal Study
PHASE3Completed
222 participants
Started: Jan 31, 2012 · Completed: Jul 31, 2014
Funding History (6)
D
Jul 18, 2016
Filing
D
Jul 29, 2014
Filing
D
May 26, 2011
Filing
D
Jan 3, 2011
Filing
D
Jul 23, 2009
Filing
D/A
Jul 23, 2009
Filing
Related Companies
Boston Scientific
acquired